Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Allergy Therapeutics plc (AGY:LON) | 11.5 0 2.6% | Mkt Cap: 706.3m
Dr Mike Mitchell | Julie Simmonds
4 pages
Companies: Allergy Therapeutics plc (AGY:LON)Cambridge Cognition Holdings Plc (COG:LON)
Companies: BNO0RXAVONCMHCHHRE/SCEMPACNICLARBBSIXHTONMURAGYGOALCKTRTNCLIGMARSINLGDRCVSGSCLPBAGCOSABDPTIMEAVODNLOXBKOOVVALYGENABZANSFTCFGTLYPHPAVCTMCLACRLGYMBURDVLPLUSDEBSDPZLSWMMX
Companies: PEN NANO AGY CNE NXQ
Companies: TXG INDV1* BCOW Z29 TXG NCYT GNS SUN AMS OMG EKF EAH IMM CLBX AGY TSTL IPO GDR HVO CTEC OXB VLG IXI VAL AVCT 123F IMCR DTXMF BCOW LSW
Companies: Allergy Therapeutics plc
